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Abstract
CytoJournal is published by an independent publisher BioMed Central, which is committed to
ensuring that the peer-reviewed biomedical research is Open Access. Since its launch, BioMed
Central has graciously supported the processing of all the articles published during CytoJournal's first
6 months. However, for long term viability, CytoJournal has to achieve financial viability to support
publication expenses. From 1st March, 2005, authors will be asked by the publisher to pay a flat
article-processing charge. This editorial discusses how a significant proportion of authors may not
have to pay this fee directly under a variety of different mechanisms such as institutional and society
memberships with BioMed Central.
Introduction
CytoJournal is published by BioMed Central, an independ-
ent publisher committed to ensuring peer-reviewed bio-
medical research is Open Access – it is universally and
freely available online to everyone, its authors retain cop-
yright, and it is archived in at least one internationally rec-
ognised free repository [1]. CytoJournal however, has taken
this further, by making all its content Open Access.
Since its launch in August 2004, BioMed Central has gra-
ciously supported the processing of all the articles pub-
lished during CytoJournal's first 6 months. However, as we
move forward it is crucial that CytoJournal develops its
own financial viability, at least to support publication
expenses. Thus, from 1st March, 2005, authors will be
asked by the publisher to pay a flat £330 (approximately
US $600/€500) article-processing charge (APC) [2]. As
explained below, a significant proportion of authors may
not have to pay the fee directly. This is because the APC
can be covered/waived under a variety of different mech-
anisms such as institutional and society memberships
with BioMed Central [2].
Please note that authors submitting any article online to Cyto-
Journal before 1st March, 2005 will not have to pay an APC,
even if it is accepted for publication after peer review.
Problems with the traditional publishing model
Traditionally, readers pay to access articles, either through
subscriptions or by paying a fee each time they download
an article. Escalating journal subscriptions have resulted
in libraries subscribing to fewer journals [3], and the range
of articles available to readers is therefore limited.
Although traditional journals publish authors' work for
free (unless there are page or colour charges), having to
pay to access articles limits how many people can read,
use and cite them. This compromises the scientific impact
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of the publication and overall visibility of the researchers
work.
Definition of Open Access
CytoJournal's Open Access policy changes the way in which
articles are published. First, all articles become freely and
universally accessible online, and so an author's work can
be read by anyone at no cost. Second, the authors hold
copyright for their work and grant anyone the right to
reproduce and disseminate the article, provided that it is
correctly cited and no errors are introduced [1]. Third, a
copy of the full text of each article is permanently archived
in an online repository separate from the journal. Cyto-
Journal's articles are archived in PubMed Central [4], the
US National Library of Medicine's full-text repository of
life science literature, and also in repositories at the Uni-
versity of Potsdam [5] in Germany, at INIST [6] in France,
and in e-Depot [7]- the National Library of the Nether-
lands' digital archive of all electronic publications.
Benefits of Open Access
Open Access has four broad benefits for science and the
general public. First, authors are assured that their work is
disseminated to the widest possible audience, given that
there are no barriers to access it. This is accentuated by the
authors being free to reproduce and distribute their work,
for example by placing it on their institution's website.
They can still use the published material for any future
plans including book chapters, monograms, and presen-
tation after due acknowledgement about its original pub-
lication. It has been shown that free online articles are
more highly cited because of their easier availability [8].
Second, the information available to researchers will not
be limited by what their library can afford, and the wide-
spread availability of articles will enhance literature
searching [9]. Third, the results of publicly funded
research will be accessible to all taxpayers and not just
those with access to a library with a subscription. Note
that this public accessibility is becoming a legal require-
ment for many countries and organizations [10]. Fourth,
a country's economy will not influence its scientists' abil-
ity to access articles because resource-poor countries (and
institutions) will be able to read the same material as
wealthier ones (although creating access to the internet is
another matter [11]).
Open Access to original peer-reviewed scientific informa-
tion to both the general public and experts alike has many
benefits. It can affect and shape the public opinion. In the
long run the availability of such information in the field
of cytopathology will translate into further progress in
cytopathology and maximize its benefits to various fields
of life sciences.
Description of APC payment
APCs will allow continued Open Access to all of CytoJour-
nal's articles. Authors are asked to pay a flat payment of
£330, during 2005, if their article is accepted for publica-
tion [2]. Waiver requests will be considered on a case-by-
case basis, by the Editor-in-Chief. Authors can circumvent
the charge by getting their institution to become a 'mem-
ber' of BioMed Central, whereby the annual membership
fee covers the APCs for all authors at that institution for
that year [12]. Current members include numerous insti-
tutions in USA, NHS England, the World Health Organi-
zation, the US National Institutes of Health, and all UK
universities [12]. Biomed Central has also opened a new
avenue which allows membership to various societies
such as different cytology, cytopathology, and pathology
societies all over the world. The members of these socie-
ties could publish in CytoJournal  without incurring an
APC. We strongly recommend readers to approach their
respective societies to become members under this provi-
sion.
No charge is made for articles that are rejected after peer
review. Many funding agencies have also realized the
importance of Open Access publishing and have specified
that their grants may be used directly to pay APCs [13].
As another avenue, Cytopathology-Foundation, Inc http:/
/www.cytopathology-foundation.org, a non-profit organ-
ization, is looking for help from appropriate organisa-
tions to support the publication cost in CytoJournal, so
that ultimately our journal will be an Open Access journal
free of any financial burden for all CytoJournal authors. We
appreciate any help in this matter to achieve this goal. You
may contact by e-mail: cytojournal@mcw.edu to extend
the support.
What the APC covers
The APC pays for the manuscript publication process. It
allows the article to be freely and universally accessible in
various formats online, and for the processes required for
inclusion in PubMed and archiving in PubMed Central, e-
Depot, Potsdam and INIST. Although some authors may
consider £330 expensive, it must be remembered that
CytoJournal does not levy additional page or color charges
on top of this fee, which can easily exceed £330 with con-
ventional journals. As the entire manuscript with color
PDF file is freely available on-line, authors do not have to
stock reprints and spend mailing charges to share the pub-
lication with their peers. The PDF files can be directly
downloaded by the interested colleague/researcher or the
author to share the PDF file through e-mail at the click of
the mouse!
With reference to conventional journals it is usually stated
in instructions to authors that- 'this journal does notPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
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reproduce color illustrations unless the cost of such repro-
duction is subsidized by the author and agreed upon in
advance'. Restricting the number of images published in a
manuscript or publishing them as black & white would
significantly compromise the publication standard we
hope to maintain for a morphology based discipline such
as cytopathology. With CytoJournal, the article being
online only, any number of color figures and photographs
can be included at no extra cost. In addition, CytoJournal
being a web based publication, a small video clip could
also be included as part of publication without extra cost.
This provision to include video clip(s) is an excellent
opportunity to improve the clarity of the details to the
readers about dynamic processes such as procedures and
methodologies [14].
Free versus Open Access
Although several journals now offer free access to their
articles online, this is different from Open Access (as
defined by the Bethesda Statement [15]). These journals
often delay free access for 6-12 months, and even when
the full text is available, readers are not allowed to repro-
duce and/or disseminate the work because of restrictions
imposed by the copyright policy. That said, CytoJournal is
not alone in the move to Open Access funded by APCs.
The British Medical Journal has recently announced that it
cannot continue to provide free access to its website [16]
and is considering various sources of revenue, including
APCs [17]. Also, the Public Library of Science has set up
new Open Access journals, and have elected to set APCs of
US$1500 for each accepted article [18]. Given that the
Public Library of Science has used television advertising to
promote journals [10], the high profile of these journals
will raise awareness of Open Access and encourage
researchers in all disciplines to understand and accept
Open Access, with APCs as an acceptable method to fund
it.
Conclusion
By providing a forum for Open Access, APCs will enable
CytoJournal  to serve the pathology, cytopathology, and
entire medical community. We believe this change will
benefit and aid scientific research in general. We hope you
will support this progress by submitting your next article
to CytoJournal.
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